Genetic complexity alters drug susceptibility of asexual and gametocyte stages of Plasmodium falciparum to antimalarial candidates
Antimicrobial Agents and Chemotherapy · 2024
DOI: 10.1128/aac.01291-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Nicola Greyling und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Genetics and Microbiology, University of Pretoria, Pretoria, South Africa. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Falciparum, Malaria, Folic Acid Antagonists. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, South African National Research Foundation, South African Medical Research Council (SAMRC).
Abstract (Originalsprache)
Malaria elimination requires interventions able to target both the asexual blood stage (ABS) parasites and transmissible gametocyte stages of Plasmodium falciparum . Lead antimalarial candidates are evaluated against clinical isolates to address key concerns regarding efficacy and to confirm that the current, circulating parasites from endemic regions lack resistance against these candidates. While this has largely been performed on ABS parasites, limited data are available on the transmission-blocking efficacy of compounds with multistage activity. Here, we evaluated the efficacy of lead antimalarial candidates against both ABS parasites and late-stage gametocytes side-by-side, against clinical P. falciparum isolates from southern Africa. We additionally correlated drug efficacy to the genetic diversity of the clinical isolates as determined with a panel of well-characterized, genome-spanning microsatellite markers. Our data indicate varying sensitivities of the isolates to key antimalarial candidates, both for ABS parasites and gametocyte stages. While ABS parasites were efficiently killed, irrespective of genetic complexity, antimalarial candidates lost some gametocytocidal efficacy when the gametocytes originated from genetically complex, multiple-clone infections. This suggests a fitness benefit to multiclone isolates to sustain transmission and reduce drug susceptibility. In conclusion, this is the first study to investigate the efficacy of antimalarial candidates on both ABS parasites and gametocytes from P. falciparum clinical isolates where the influence of parasite genetic complexity is highlighted, ultimately aiding the malaria elimination agenda.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Genetics and Microbiology, University of Pretoria, Pretoria, South Africa.
- Institute for Sustainable Malaria Control, University of Pretoria, Pretoria, South Africa.
- Department of Medicine, University of California-San Francisco, San Francisco, California, USA.
- Medicines for Malaria Venture, Geneva, Switzerland.
ORCID-Profile: Nicola Greyling, Bryan Greenhouse, Lyn-Marié Birkholtz
Förderung
- NIAID NIH HHS
- South African National Research Foundation
- South African Medical Research Council (SAMRC)
- Medicines for Malaria Venture (MMV)
Zitieren
APA
Greyling, N., van der Watt, M., Gwarinda, H., van Heerden, A., Greenhouse, B., Leroy, D., Niemand, J., & Birkholtz, L. M. (2024). Genetic complexity alters drug susceptibility of asexual and gametocyte stages of Plasmodium falciparum to antimalarial candidates. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01291-23
Vancouver
Greyling N, van der Watt M, Gwarinda H, van Heerden A, Greenhouse B, Leroy D, et al. Genetic complexity alters drug susceptibility of asexual and gametocyte stages of Plasmodium falciparum to antimalarial candidates. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.01291-23
BibTeX
@article{Greyling2024,
author = {Greyling, Nicola and van der Watt, Mariëtte and Gwarinda, Hazel and van Heerden, Ashleigh and Greenhouse, Bryan and Leroy, Didier and Niemand, Jandeli and Birkholtz, Lyn-Marié},
title = {Genetic complexity alters drug susceptibility of asexual and gametocyte stages of Plasmodium falciparum to antimalarial candidates},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
doi = {10.1128/aac.01291-23}
}
EUVIMED